Holdings of Casdin Capital, LLC
38 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 78.6 % of the equity sleeve
Sector breakdown
- Health care 8.0 %
- Unattributed 92.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 98.5 %
- BE 1.3 %
- KY 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 36 | 1.3B $ | 98.46 % |
| 2 | BE | 1 | 16.3M $ | 1.25 % |
| 3 | KY | 1 | 3.7M $ | 0.29 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Revolution Medicines Inc | 2,577,333 | 250.6M $ | |
| 2 | GeneDx Holdings Corp | 3,007,164 | 193.1M $ | |
| 3 | Relay Therapeutics Inc | 14,418,574 | 143.5M $ | |
| 4 | BioLife Solutions Inc | 5,957,165 | 113.7M $ | |
| 5 | Standard BioTools Inc | 88,783,856 | 81.6M $ | |
| 6 | Illumina Inc | 530,000 | 65.3M $ | |
| 7 | Structure Therapeutics Inc | 1,175,000 | 56.6M $ | |
| 8 | 10X Genomics Inc | 2,275,000 | 48.3M $ | |
| 9 | Denali Therapeutics Inc | 1,840,000 | 35.3M $ | |
| 10 | Beam Therapeutics Inc | 1,350,000 | 32.2M $ | |
| 11 | Guardant Health Inc | 315,000 | 29.1M $ | |
| 12 | Neurogene Inc | 1,420,361 | 28.6M $ | |
| 13 | Alnylam Pharmaceuticals Inc | 75,000 | 24.8M $ | |
| 14 | Maze Therapeutics Inc | 758,857 | 22.7M $ | |
| 15 | Scholar Rock Holding Corp | 350,000 | 17.2M $ | |
| 16 | AGOMAB THERAPEUTICS SA | 1,550,000 | 16.3M $ | |
| 17 | Hims & Hers Health Inc | 700,000 | 14.5M $ | |
| 18 | Taysha Gene Therapies Inc | 3,250,000 | 14.5M $ | |
| 19 | Tempus AI Inc | 294,127 | 13.3M $ | |
| 20 | Septerna Inc | 553,268 | 13.3M $ | |
| 21 | GRAIL Inc | 230,000 | 11.9M $ | |
| 22 | Prime Medicine Inc | 3,167,175 | 11M $ | |
| 23 | Personalis Inc | 1,600,000 | 10.2M $ | |
| 24 | Quest Diagnostics Inc | 50,000 | 9.8M $ | |
| 25 | Veracyte Inc | 276,308 | 8.9M $ | |
| 26 | Intellia Therapeutics Inc | 355,000 | 4.6M $ | |
| 27 | Disc Medicine Inc | 65,000 | 4.2M $ | |
| 28 | Moderna Inc | 75,000 | 3.8M $ | |
| 29 | Adlai Nortye Ltd. | 538,461 | 3.7M $ | |
| 30 | Monte Rosa Therapeutics Inc | 186,014 | 3.1M $ | |
| 31 | Absci Corp | 973,260 | 2.9M $ | |
| 32 | Century Therapeutics Inc | 1,228,190 | 2.8M $ | |
| 33 | BridgeBio Oncology Therapeutics Inc | 282,312 | 2.5M $ | |
| 34 | Contineum Therapeutics Inc | 148,333 | 1.9M $ | |
| 35 | Pacific Biosciences of California Inc | 723,767 | 955.4K $ | |
| 36 | Recursion Pharmaceuticals Inc | 165,323 | 507.5K $ | |
| 37 | Tenaya Therapeutics Inc | 361,969 | 250.6K $ | |
| 38 | Ginkgo Bioworks Holdings Inc | 36,493 | 223.7K $ | |